Table 2 Comparison of incidence of adverse events between the two groups
From: Safety and efficacy of therapeutic hypothermia in neonates with mild hypoxic-ischemic encephalopathy
Variable | TH group n = 31 | Non-TH group n = 40 | P Value |
|---|---|---|---|
Hypotension requires vasoactive drug treatment | 4 (12.9) | 1 (2.5) | 0.218 |
PPHN requires NO treatment and FiO > 0.50 | 1 (3.2) | 0 (0.0) | 0.898 |
Blood transfusions required for coagulation dysfunction | 3 (9.7) | 0 (0.0) | 0.157 |
Hypoglycemia | 7 (22.6) | 7 (17.5) | 0.594 |
Stress hyperglycemia | 7 (22.6) | 3 (7.5) | 0.142 |
Liver insufficiency | 5 (16.1) | 2 (5.0) | 0.247 |
Renal insufficiency | 2 (6.5) | 0 (0.0) | 0.365 |
Thrombocytopenia | 5 (16.1) | 2 (5.0) | 0.247 |
Septicemia | 5 (16.1) | 4 (10.0) | 0.682 |